𝔖 Bobbio Scriptorium
✦   LIBER   ✦

The use of combination therapy in leukemia remission

✍ Scribed by Sanford Leikin; Charles Brubaker; John Hartmann; M. Lois Murphy; James Wolff

Publisher
John Wiley and Sons
Year
1969
Tongue
English
Weight
475 KB
Volume
24
Category
Article
ISSN
0008-543X

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

Delay to institution of therapy and indu
Delay to institution of therapy and induction of remission using single-drug or combination–disease-modifying antirheumatic drug therapy in early rheumatoid arthritis
✍ Timo MΓΆttΓΆnen; Pekka Hannonen; Markku Korpela; Martti NissilΓ€; Hannu Kautiainen; πŸ“‚ Article πŸ“… 2002 πŸ› John Wiley and Sons 🌐 English βš– 59 KB πŸ‘ 1 views

## Abstract ## Objective To study the impacts of 1) the delay from the onset of symptoms to the institution of disease‐modifying antirheumatic drug (DMARD) therapy, 2) two treatment strategies (treatment with a combination of DMARDs or with a single drug), and 3) the presence of HLA–DRB1 alleles (

Selective use of daunorubicin for remiss
Selective use of daunorubicin for remission-induction chemotherapy in acute non-lymphoblastic leukemia
✍ B. S. Shaikh; J. B. Dougherty; R. W. Hamilton; J. O. Ballard; S. B. Patel; N. R. πŸ“‚ Article πŸ“… 1980 πŸ› John Wiley and Sons 🌐 English βš– 396 KB πŸ‘ 2 views

Twenty-eight patients with acute non-lymphoblastic leukemia (ANLL) were started on induction chemotherapy consisting of Cytosine Arbinoside (Ara C) and 6 thioguanine (TG). Daunoruhicin (DNR) was used selectively in 20 of 28 patients who failed to respond by day 14 to the Ara C and TG combination. Se